Clinical Trial Update: Comparative Efficacy, Safety, PK, and Immunogenicity Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating comparative efficacy, safety, pharmacokinetics, and immunogenicity in postmenopausal osteoporosis; sponsored by Luye Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: ACTIVE_NOT_RECRUITING